http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2021904-A6

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-650952
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
filingDate 1989-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ffb104f5302f586a712acd521e9db88
publicationDate 1991-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2021904-A6
titleOfInvention PROCEDURE TO PREPARE A PHARMACEUTICAL COMPOSITION BASED ON A PIPERACINACARBOXILIC ACID.
abstract PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION BASED ON PIPERACINACARBOXILIC ACID. IT INCLUDES MIXING AN ACID [R- (E)] - 4- (3-PHOSPHONO-2-PROPENIL) -2-PIPERACINCARBOXILICO OF FORMULA (I) OR A HYDRATE OR A SALT OF THE SAME, WITH A VEHICLE OR THINNER PHARMACEUTICALLY ACCEPTABLE, HOW TO PRODUCE A DOSAGE UNIT FORM CONTAINING APPROXIMATELY 0.25 TO 0.400 MG OF THE FORMULA COMPOUND (I). THE COMPOSITION SO OBTAINED HAS ACTIVITY ON THE CENTRAL NERVOUS SYSTEM.
priorityDate 1987-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131766

Total number of triples: 30.